INSIGHTS ON DRUG DEVELOPMENT

• Peptones And Vaccines: A Synergistic Approach To Enhanced Production And Efficiency

  Enhance your vaccine manufacturing with peptones. Explore their benefits, analyze data-driven productivity gains, and learn integration strategies in this informative, on-demand session.

• Quality By Design: The Importance Of Reference Standards In Drug Development

  Learn more about the comprehensive lifecycle management of reference standards, encompassing qualification, characterization, and storage procedures.

• Advancing Drug Development With Optimized LC-MS/MS Bioanalysis

  Explore the critical role of sample preparation optimization and the application of liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in bioanalytical method development.

• Assessing Developability And Designing Advanceable Formulations From The Start

  Discover how early developability assessments and a quality-by-design approach can streamline formulation, reduce risk, and accelerate your path to successful, cost-effective drug development.

• Fast And Accurate Detection Of Alzheimer's Disease Targets

  9/17/2024

  In this study, the detection of three Alzheimer’s disease targets are highlighted: Human BDNF (Brain-derived neurotrophic factor), Tau, and TREM2 (Triggering receptor expressed on myeloid cells 2).

• Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety

  9/16/2025

  Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.

• Characterizing Binding Interactions By ITC

  4/24/2025

  Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.

• Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights

  3/5/2025

  Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.

• EMA Support For Rare Disease Therapies

  6/10/2025

  Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.